Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Blood Purification is Scopus-indexed (Q2, CiteScore 4.6), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 0253-5068Verify ISSN ↗1421-9735Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 24 / 88 | 73rd | Q2 |
| Hematology | 47 / 151 | 69th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q2, CiteScore 4.6.
Blood Purification is Q2 in Nephrology (rank 24 of 88) and Q2 in Hematology (rank 47 of 151), by CiteScore 2025.
Blood Purification is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.648, quartile Q2, with an H-index of 76.
Blood Purification is published by S. Karger AG. Its print ISSN is 0253-5068 and its online ISSN is 1421-9735.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Blood Purification has an h-index of 88 and a 2-year mean of 1.75 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q2. On 2-year citations it ranks #31 of 87 Scopus journals in Nephrology.
Blood Purification published 100 papers in 2025; its busiest recent year was 2019 with 167. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from China (18.2%), Japan (11%) and United States (10.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.